-
BEYOND THE REAGENT COST: BUDGET IMPACT OF REDUCING LOW-VALUE BASIC COAGULATION TESTING IN AMBULATORY CARE
Aug 11, 2026, 17:16 PM -
REPRODUCIBILITY, AUDITABILITY, AND THE PROMPT DEPENDENCY PROBLEM: AN ASSESSMENT OF METHODOLOGICAL MATURITY OF THE AI EVIDENCE BASE UNDERPINNING RAISE
Aug 11, 2026, 17:16 PM -
ESTIMATING QUALITY-ADJUSTED LIFE EXPECTANCY POPULATION NORMS FOR SOUTH KOREA
Aug 11, 2026, 17:16 PM -
PATIENT-CENTERED EVIDENCE ON AWARENESS, UTILIZATION, AND EXPERIENCE OF NIGERIA'S BASIC HEALTH CARE PROVISION FUND: FINDINGS FROM A NATIONAL BASELINE KAP SURVEY
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF INTRODUCING SEMAGLUTIDE 2.4 MG FOR THE MANAGEMENT OF OBESITY IN THE KINGDOM OF SAUDI ARABIA: A MINISTRY OF DEFENSE AND AVIATION (MODA) PERSPECTIVE
Aug 11, 2026, 17:16 PM -
BEYOND DISCLOSURE: CONFLICT-OF-INTEREST GOVERNANCE IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
DIY HEALTHCARE: THE RISE OF AT HOME HEALTH TESTING IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
FIT FOR PURPOSE? PURPOSE BUILT ARTIFICIAL INTELLIGENCE (AI) TOOLS VS GENERAL PURPOSE LARGE-LANGUAGE MODEL (LLM) FOR DATA EXTRACTION IN EVIDENCE SYNTHESIS
Aug 11, 2026, 17:16 PM -
TRIAL-INELIGIBLE PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS FOR ADVANCED NSCLC: A SYSTEMATIC REVIEW OF REAL-WORLD EVIDENCE
Aug 11, 2026, 17:16 PM -
GLOBAL TRENDS AND DISPARITIES IN THE USE OF CLINICAL OUTCOME ASSESSMENTS IN CLINICALTRIALS.GOV, 2015-2025: AN AI-ENABLED LANDSCAPE ANALYSIS
Aug 11, 2026, 17:16 PM -
WEIGHT MANAGEMENT PRESCRIBING IN ENGLAND: FINDINGS FOLLOWING THE ROLLOUT TO PRIMARY CARE
Aug 11, 2026, 17:16 PM -
LESSONS LEARNED FROM THE WELL-ESTABLISHED USE PATHWAY: A RETROSPECTIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
PREPARING FOR JOINT CLINICAL ASSESSMENT: COMPARING HTA COMPARATORS, CLINICAL PRACTICE, AND REAL-WORLD FIRST-LINE NSCLC TREATMENT IN THE EU4 + UK
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE "INVISIBLE" BURDEN: ESTIMATING UNDIAGNOSED CARDIO-RENAL-METABOLIC CONDITIONS USING LINKED EMR-CLAIMS DATA
Aug 11, 2026, 17:16 PM -
REDUCING INFLUENZA BURDEN IN OLDER ALGERIANS: COST-EFFECTIVENESS ANALYSIS OF HIGH DOSE VS STANDARD DOSE INACTIVATED INFLUENZA VACCINE IN ADULTS AGED 75 AND OLDER
Aug 11, 2026, 17:16 PM -
HEALTH TECHNOLOGY ASSESSMENT OF OUT-LICENSED CHINESE-ORIGIN ONCOLOGY ASSETS: A DESCRIPTIVE CASE SERIES OF COMPLETED NICE APPRAISALS
Aug 11, 2026, 17:16 PM -
A SENTENCE-LEVEL ASSESSMENT FRAMEWORK FOR EVALUATING AI-GENERATED STUDY SUMMARIES AGAINST EXPERT-CURATED CLINICAL OVERVIEW
Aug 11, 2026, 17:16 PM -
A PROOF-OF-CONCEPT FRAMEWORK FOR ADAPTING EQ-5D-5L UTILITY ESTIMATES FOR HEALTH TECHNOLOGY ASSESSMENT IN MENA: AN ASTHMA CASE STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF PERIOPERATIVE PEMBROLIZUMAB AND ENFORTUMAB VEDOTIN FOR THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER PATIENTS WHO ARE INELIGIBLE FOR CISPLATIN-BASED CHEMOTHERAPY IN BELGIUM
Aug 11, 2026, 17:16 PM -
DIPEPTIDYL PEPTIDASE-4 INHIBITOR-ASSOCIATED HYPERKALEMIA: A DISPROPORTIONALITY ANALYSIS IN THE FAERS DATABASE
Aug 11, 2026, 17:16 PM
